Table 2.

Heritability estimates using variance components and ANOVA-based methods. p-values are shown in italics (p < 0.001) and in bold (p < 0.05).

	clones	n	ln transformed		p	residualsa		p
			H2	s.e.		H2	s.e.
variance components
AS	24	151	0.39	0.16	0.0174	0.34	0.18	0.0406
CQ	25	174	0.17	0.13	0.08	0.04	0.12	0.3718
DHA	25	164	0.30	0.15	0.0278	0.25	0.16	0.0666
LUM	20	154	0.60	0.11	4.84 × 10−5	0.57	0.12	0.0002
MFQ	26	175	0.79	0.06	2.85 × 10−9	0.77	0.06	1.47 × 10−8
QN	20	151	0.65	0.10	7.56 × 10−5	0.62	0.11	8.50 × 10−5
PRR24	27	184	0	b	—	0.00	0.00	0.5
PRR48	27	184	0	b	—	0.03	0.10	0.3704
ANOVA
AS	24	61c	0.33	0.15	0.0123	0.27	0.15	0.0339
CQ	25	66c	0.22	0.14	0.0551	0.08	0.14	0.2730
DHA	25	64c	0.31	0.14	0.0143	0.25	0.15	0.0434
LUM	20	54c	0.56	0.13	<0.0001	0.52	0.14	0.0003
MFQ	26	69c	0.69	0.09	<0.0001	0.67	0.09	<0.0001
QN	20	55c	0.49	0.14	0.0004	0.52	0.13	0.0002
PRR24	27	74c	0.02	0.13	0.4148	0.09	0.13	0.2377
PRR48	27	74c	−0.02	0.13	0.5408	0.05	0.13	0.3514

^aResiduals were generated from multiple regression of phenotype against treatment regimen, patient age and gender.

^bBoundary of parameter space encountered: s.e. and p-value not output by SOLAR.

^cn is lower for the ANOVA as only CI parasites are used.